Analystreport

Minerva Neurosciences (NASDAQ:NERV) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.

Minerva Neurosciences, Inc  (NERV) 
Last minerva neurosciences, inc earnings: 3/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.minervaneurosciences.com/investor-relations